Shamrock Medicine Strengthens Psychiatric Services with New Mental Health Provider Ilyssa Krane
Philadelphia-based primary care practice expands mental health services team with board-certified psychiatric nurse practitioner to meet growing community needs
PHILADELPHIA, PA, UNITED STATES, April 21, 2025 / EINPresswire.com / -- Shamrock Medicine, a provider of integrated primary and psychiatric care services in the Greater Philadelphia area, today announced the addition of Ilyssa Krane, PMHNP-BC, to its mental health team. The expansion comes as demand for accessible psychiatric services continues to grow throughout the region.
Ilyssa Krane, a board-certified psychiatric mental health nurse practitioner, brings substantial clinical experience to practice. She holds a bachelor's degree in psychology from the University of Pittsburgh, a bachelor's degree in nursing from Holy Family University, and a master's in nursing as a Psychiatric Mental Health Nurse Practitioner from Thomas Jefferson University.
'Adding Ilyssa to our team enhances our ability to provide comprehensive mental health care alongside our primary care services,' said Dr. Peter Kelly, Owner and Spokesperson of Shamrock Medicine. 'Her background working in both medical-surgical and outpatient settings aligns perfectly with our integrated approach to healthcare.'
Prior to joining Shamrock Medicine, Krane worked at Thomas Jefferson University Hospital and Children's Hospital of Philadelphia's Center for Advanced Behavioral Healthcare, developing expertise in diverse patient populations and treatment approaches.
Shamrock Medicine operates three offices serving patients across Pennsylvania and New Jersey. The main office is located in Philadelphia, with additional locations in Ambler, PA at 7 E Skippack Pike, Suite 304, and Cherry Hill, NJ at 911 Kings Highway S.
The practice distinguishes itself through its integrated healthcare model that combines primary and psychiatric care under one roof. Patients can communicate with providers via a text-based platform for appointments, lab results, and prescription refills, eliminating common barriers to accessing healthcare.
'Best experience I've had in years with a primary caregiver!' said Irene T., a patient at Shamrock Medicine.
The practice accepts multiple insurance plans including Aetna, Cigna, Highmark BCBS, Independence BCBS, Humana, Medicare, Tricare, UMR, and United Insurances, making quality healthcare accessible to a broad patient population in Philadelphia, Ambler, and Cherry Hill.
'Excellent doctor's office. Very kind and informative,' noted John J., another patient of the practice.
Shamrock Medicine's approach focuses on personalized care, with providers taking time to listen to patient concerns and develop individualized treatment plans. The practice intentionally limits patient volume to ensure each person receives appropriate attention and care.
'I am pleased with Shamrock Medicine. I appreciate the 1 on 1 attention that I receive,' shared Pamela R., reflecting the practice's commitment to personalized service.
For more information about Shamrock Medicine and its services, call +1 215.585.2342 or visit https://shamrockmedicine.com/contact-us/.
###
About Shamrock Medicine
Shamrock Medicine ( https://shamrockmedicine.com/meet-our-team/ ) is a leading provider of comprehensive psychiatric care and personalized wellness services in the Greater Philadelphia area. The practice offers a warm and welcoming environment where adults and children (over the age of five) can receive compassionate and effective treatment for a wide range of mental health conditions. The team at Shamrock Medicine is dedicated to building strong patient-provider relationships and developing individualized treatment plans that promote long-term mental well-being.
Clinic Locations:
Philadelphia Clinic
407 South 10th Street Suite 101
Philadelphia, PA 19147
Phone: 215.585.2342
https://maps.app.goo.gl/xrpRUEShp7y17EiT8
Ambler Clinic
7 E Skippack Pike, Suite 304
Ambler, PA 19002
https://maps.app.goo.gl/4Lf4xuArU84722uS7
Cherry Hill, NJ Clinic
911 Kings Highway S
Cherry Hill, NJ, 08034
Phone: 856.553.1355
https://maps.app.goo.gl/KSt9NrbBzgq1mBin6
Note to Editors
• For further information, interviews, or media inquiries, please contact: Dr. Peter Kelly Owner and Spokesperson Shamrock Medicine Phone: +1 215.585.2342 Email: info (at) shamrockmedicine (dot) com.
• The practice accepts various insurance plans, including Aetna, Cigna, Highmark BCBS, Independence BCBS, Humana, Medicare, and United Insurances. Please visit their website for more details on accepted insurances and services provided.
End of Press Release.
Dr. Peter Kelly
Shamrock Medicine
+1 215-585-2342
email us here
Visit us on social media:
Facebook
LinkedIn
Instagram
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indianapolis Star
8 hours ago
- Indianapolis Star
FDA: More cucumbers, ready-to-eat products recalled in growing salmonella outbreak
A Maryland food company has recalled specific salsa and cucumber products because they were made with cucumbers that are possibly contaminated with salmonella. TGD Cuts, LLC of Jessup, Maryland, is recalling some tub and tray products because they contained cucumbers from Boynton Beach, Florida-based Bedner Growers Inc., which have been linked to a salmonella outbreak. TGD Cuts distributed the affected products, which included salsas, sliced cucumbers and cucumber spears, to retail and foodservice locations in Maryland, Virginia, Pennsylvania, New Jersey, and North Carolina, according to the Food and Drug Administration (FDA). The products had use-by dates ranging from May 20 to May 28 and are unlikely to be in stores or being used. No illnesses have been reported in connection with the products, the FDA said. Egg recall: Brown eggs sold at some Walmart stores have salmonella risk The initial May 19 recall involved cucumbers sold directly to consumers at Bednar's Farm Fresh Market, according to notices published May 19 by the Centers for Disease Control and Prevention (CDC) and the FDA. Subsequent recalls have been announced by grocers such as Harris Teeter, Kroger and Walmart for repackaged cucumbers for resale under different brand names or those used in ready-to-eat products, including vegetable trays and salads. The cucumbers, distributed by Fresh Start Produce Sales of Delray, Florida, also led to Target recalling individual cucumbers on May 30, specifically cucumber two-packs and various prepared foods products. In addition to the growing cucumber-related recall, other products have been recalled recently for potential salmonella contamination. The FDA on May 28 upgraded a recall of tomatoes distributed in three southern states to a Class I recall, meaning consumption of the food could cause serious health complications or lead to death. Then, on June 6, the CDC and FDA linked brown eggs sold in nine states – including at some Walmart stores – to an ongoing Salmonella Enteritidis outbreak, in which 79 people have been sickened and at least 21 hospitalized. Customers who purchased any products from TGD Cuts should get rid of them or return them for a full refund. Here is the list of products recalled due to a possible salmonella risk. Salmonella poisoning causes about 1.35 million illnesses, 26,500 hospitalizations, and 420 deaths each year in the U.S., according to the CDC and FDA. Symptoms, which include diarrhea, fever and stomach cramps, will usually occur six hours to six days after exposure and may last up to seven days. Symptoms from severe infections may include aches, headaches, elevated fever, lethargy, rashes, and blood in urine or stool. Mike Snider is a reporter on USA TODAY's Trending team. You can follow him on Threads, Bluesky, X and email him at mikegsnider & @ & @mikesnider & msnider@
Boston Globe
12 hours ago
- Boston Globe
Will Trump's policies kill Massachusetts' life sciences leadership?
Advertisement Although the industry is centered in eastern Massachusetts, there's a statewide benefit from all the tax dollars those businesses and workers pay. Get The Gavel A weekly SCOTUS explainer newsletter by columnist Kimberly Atkins Stohr. Enter Email Sign Up In all, Massachusetts organizations — including universities, research institutes, and hospitals — received $3.5 billion in funding from the National Institutes of Health. Massachusetts-headquartered companies raised $3.26 billion in venture capital funding. Among all drugs in the development pipeline in the United States, 15 percent were being made by companies headquartered in Massachusetts. But actions taken by President Trump and his administration — cutting funding for scientific research and universities, flirting with tariffs, fanning skepticism about vaccines — threaten to devastate the ecosystem. Today, the industry is at a precipice, and uncertainty abounds. Some companies are already feeling the pinch of terminated federal grants, while others are anxious about what might come. Taken together, Trump's policies could force some companies and scientists to take their money, talents, and products overseas. Advertisement Christopher Locher, CEO of Lowell-based Versatope Therapeutics, which develops a platform to deliver vaccines and therapeutics, said he worries the Greater Boston life sciences ecosystem is 'being flushed down the toilet.' For example, Trump is Trump's funding cuts are already having a large impact on some local companies. Part of the problem is the Trump administration isn't only cutting funding, but it's picking which technologies to fund — in some cases apparently based on politics more than science. Take flu vaccines. The Trump administration recently announced a $500 million campaign to fund the development of a universal flu vaccine, which doesn't require annual updates, using technology being worked on But simultaneously, he cut funding for other work on a universal flu vaccine. Versatope Therapeutics got $14 million in NIH funding and spent five years developing a universal flu vaccine. It had approval from the US Food and Drug Administration to begin clinical trials when Trump terminated the contract's remaining $8 million, with the reason given being 'convenience,' Locher said. Trump also Advertisement Company executives say decisions by Trump officials to disinvest in vaccine-related technology — and concerns about whether government will approve new technology — means it's nearly impossible to find private investment funding to replace lost federal dollars. 'We're faced with bankruptcy in the very near future,' Locher said. Ironically, given Trump's stated commitment to bringing businesses back to the United States, one potential option Locher is eyeing is opening a subsidiary abroad. Conducting clinical trials would be cheaper in another country, whether in Europe, Australia, or China, Locher said, and some countries are offering financial incentives to American companies to relocate. Companies also face a potential workforce brain drain. There have been MassBio officials said China has less rigorous — but faster — safety and research protocols than the US. Australia allows a faster timeline for clinical trials. If regulatory approval of medicines is held up because the FDA is understaffed, companies may seek European regulatory approval instead. The loss of talent to foreign countries will be compounded if the pipeline of local university graduates dries up. One draw for life sciences companies to Boston/Cambridge is the presence of elite schools like Harvard and MIT, with their potential for faculty collaboration and skilled graduates. Advertisement Trump is trying to Chip Clark, CEO at Vibrant Biomedicines in Cambridge, said cuts to university research funding both 'shrink the pipeline of great ideas' that form the basis for many biotech startups and translate to fewer available scientists. Clark said the administration's policies 'seem like a deliberate attempt to try to cede scientific leadership to Europe and Japan and Korea and China. ... They will be delighted to capitalize on our talent, technology, and investment capital to make their robust biotech sectors grow and ultimately compete successfully against the US industry,' he said. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, said he has postdocs with US visas applying for jobs in Europe, and others who were accepted to work at Harvard but are going elsewhere. 'The fact that places like Harvard and MIT and American universities are magnets for the best and brightest from around the world is what's driven our technology economy and certainly the Boston/Cambridge ecosystem,' Ingber said. 'With this uncertainty, I fear we'll lose a generation.' Ingber, who was forced to stop work on two government-funded projects on drugs designed to prevent injury from radiation exposure, compared administration policies to 'eating seed corn' needed to grow crops. Advertisement Trump's vendetta will undermine one of the most vibrant state economies in the country and set back American science by years. And it's not just eastern Massachusetts that will pay a price; the entire country will. As Ingber noted, it might take years to see the impact of medicines or technologies that aren't developed because of these shortsighted cuts. Editorials represent the views of the Boston Globe Editorial Board. Follow us
Epoch Times
a day ago
- Epoch Times
Nasal, Baby Teething Swabs Recalled Nationwide Over Microbial Contamination Fears
New Jersey-based Church & Dwight Co., Inc. is recalling three nasal and baby teething swab products due to potential fungal contamination in the cotton swab components, the company said in a June 6 The recall is applicable to three products: Zicam Cold Remedy Nasal Swabs designed to tackle the common cold, Zicam Nasal AllClear Swabs used for cleansing, and Orajel Baby Teething Swabs aimed at soothing teething discomfort among toddlers and infants.
